Lessons from chylomicron retention disease: a potential new approach for the treatment of hypercholesterolemia?

Noel Peretti
  • Expert Opinion on Orphan Drugs, February 2018, Taylor & Francis
  • DOI: 10.1080/21678707.2018.1438259
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: